Navigate Shifting Reimbursement Criteria for Molecular Testing
At TELCOR, we’ve recently identified a notable shift in how molecular claims specifically associated with CPT code...
Stay informed with expert insights, case studies, and tools to help your lab improve performance and make smarter revenue decisions.
At TELCOR, we’ve recently identified a notable shift in how molecular claims specifically associated with CPT code...
Recent legislation in Florida now requires patient overpayments to be refunded within 30 days of identification,...
TELCOR has identified ongoing processing challenges with BCBS New Jersey that laboratories should be aware of. When...
TELCOR has identified a recent process change with BCBSNebraska impacting payment timelines. As of November 1, 2025,...
To reduce denials and protect molecular testing revenue it is imperative for laboratories to be aware of payer policy...